Cargando…

Osilodrostat‐induced adrenal insufficiency in a patient with Cushing's disease

Cushing's disease is a rare condition caused by a benign pituitary tumor underlying adrenocorticotropic hormone excess. Medical treatment is implemented when surgical resection is not curative. We present a case of Cushing's disease with recurrence of macroadenoma who developed iatrogenic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ekladios, Catherine, Khoury, Jessica, Mehr, Shahzad, Feghali, Krystel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675382/ https://www.ncbi.nlm.nih.gov/pubmed/36415717 http://dx.doi.org/10.1002/ccr3.6607

Ejemplares similares

Adrenal Cushing’s Syndrome Treated With Preoperative Osilodrostat and Adrenalectomy
por: Malik, Risha B., et al.
Publicado: (2022)

Cushing’s Syndrome in Adenocarcinoma of Lung Responding to Osilodrostat
por: Heleno, Caio Teixeira, et al.
Publicado: (2023)

Randomized Trial of Osilodrostat for the Treatment of Cushing Disease
por: Gadelha, Mônica, et al.
Publicado: (2022)

Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat
por: Blew, Kathryn, et al.
Publicado: (2023)

ODP340 NOVEL THERAPY OSILODROSTAT AS AN OPTION FOR RECURRENT CUSHING'S DISEASE
por: Marin, Luis Madera, et al.
Publicado: (2022)

Clinical Utility of Osilodrostat in Cushing’s Disease: Review of Currently Available Literature
por: Perosevic, Milica, et al.
Publicado: (2023)

Long-term outcomes of osilodrostat in Cushing’s disease: LINC 3 study extension
por: Fleseriu, Maria, et al.
Publicado: (2022)

Osilodrostat in Cushing’s disease: the management of its efficacy and the pitfalls of post-surgical results
por: Antonini, Simone, et al.
Publicado: (2022)

Cushing’s syndrome: a combined treatment with etomidate and osilodrostat in severe life-threatening hypercortisolemia
por: Dzialach, Lukasz, et al.
Publicado: (2022)

THU038 Osilodrostat Dosing In Cushing’s Disease: A Pooled Analysis Of The LINC Program
por: Newell-Price, John, et al.
Publicado: (2023)

Treatment of Cushing’s syndrome with osilodrostat: practical applications of recent studies with case examples
por: Fleseriu, Maria, et al.
Publicado: (2022)

Iatrogenic Cushing's Syndrome with Subsequent Adrenal Insufficiency in a Patient with Psoriasis Vulgaris Using Topical Steroids
por: Pektas, Suzan Demir, et al.
Publicado: (2017)

Adrenal Insufficiency under Standard Dosage of Glucocorticoid Replacement after Unilateral Adrenalectomy for Cushing's Syndrome
por: Fujii, Kentaro, et al.
Publicado: (2016)

PMON163 Effect of Osilodrostat on Androgens and Adrenal Hormones in Patients With Cushing's Disease: Long-Term Findings From the Phase III, Prospective LINC 3 Study
por: Fleseriu, Maria, et al.
Publicado: (2022)

Primary Adrenal Insufficiency due to Cryptococcus With Persistent Adrenal Enlargement and Insufficiency
por: Price, Catherine E., et al.
Publicado: (2023)

SUN-454 Rationale and Methods for a Phase II Trial Evaluating Osilodrostat in Pediatric Patients with Cushing's Disease
por: Savage, Martin, et al.
Publicado: (2019)

Long-term efficacy and safety of osilodrostat in patients with Cushing’s disease: results from the LINC 4 study extension
por: Gadelha, Mônica, et al.
Publicado: (2023)

Adrenal venous sampling in a patient with adrenal Cushing syndrome
por: Builes-Montaño, Carlos Esteban, et al.
Publicado: (2015)

Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone
por: Epperla, Narendranath, et al.
Publicado: (2015)

Adrenal Insufficiency Secondary to Septic Shock in a Male Patient with Iatrogenic Cushing’s Syndrome: 2 sides of the Same Coin?
por: Foppiani, Luca
Publicado: (2021)

Efficacy and Safety of Osilodrostat in Paraneoplastic Cushing Syndrome: A Real-World Multicenter Study in France
por: Dormoy, Alexandre, et al.
Publicado: (2022)

Severe Cushing’s syndrome from an ectopic adrenocorticotropic hormone-secreting neuroendocrine tumour treated by osilodrostat
por: Hána, Václav, et al.
Publicado: (2023)

Prolonged adrenal insufficiency after unilateral adrenalectomy for Cushing's Syndrome
por: Kulshreshtha, Bindu, et al.
Publicado: (2015)

PSAT044 Management of Severe Cushing's Syndrome in a Patient with Cyclical Ectopic ACTH Production Treated with Osilodrostat.
por: Obeid, Hiba, et al.
Publicado: (2022)

Topical glucocorticoid application causing iatrogenic Cushing’s syndrome followed by secondary adrenal insufficiency in infants: two case reports
por: Matejek, Nicola, et al.
Publicado: (2022)

Long-Term Control of Urinary Free Cortisol With Osilodrostat in Patients With Cushing’s Disease: Final Results From the LINC 2 Study
por: Fleseriu, Maria, et al.
Publicado: (2021)

Predictive Accuracy of Delta Cortisol on Recovery of Adrenal Function in Patients With Drug Induced Cushing’s Syndrome With Secondary Adrenal Insufficiency
por: San, Bo Bo
Publicado: (2021)

Cushing syndrome in pregnancy secondary to adrenal adenoma
por: Chang, Ikjin, et al.
Publicado: (2013)

Acute Kidney Injury after Pembrolizumab-Induced Adrenalitis and Adrenal Insufficiency
por: Hanna, Ramy M., et al.
Publicado: (2018)

Coronary Spastic Angina Induced by Adrenal Insufficiency
por: Otsuka, Yuki, et al.
Publicado: (2020)

LBMON177 Dosing And Titration Of Osilodrostat In A Real-world Cohort Of US Patients With Endogenous Cushing's Disease: Analysis Of The ILLUSTRATE Study
por: Ioachimescu, Adriana Gabriela, et al.
Publicado: (2022)

Functional Adrenal Collision Tumor in a Patient with Cushing's Syndrome
por: Zhou, Cathy, et al.
Publicado: (2020)

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease
por: Fleseriu, Maria, et al.
Publicado: (2015)

ODP639 The Occurrence and Predictors of Postoperative Adrenal Insufficiency for Patients With Subclinical Cushing's Syndrome
por: Da-long, Zhu, et al.
Publicado: (2022)

Adrenomyeloneuropathy Presenting With Adrenal Insufficiency
por: Park, Hee Dong, et al.
Publicado: (2013)

Multiple endocrine neoplasia type 1 and adrenal Cushing's
por: Vithian, Karunakaran, et al.
Publicado: (2011)

Bilateral Primary Adrenal Lymphoma Presenting with Adrenal Insufficiency
por: Holm, Jakob, et al.
Publicado: (2012)

Adrenal Crisis Associated With COVID-19 Vaccination in Patients With Adrenal Insufficiency
por: Kurematsu, Yukako, et al.
Publicado: (2023)

Refractory hypotension due to Nivolumab-induced adrenal insufficiency
por: Tsukizawa, Yoshiaki, et al.
Publicado: (2018)

Coexistence of Cushing Disease With a Solitary Adrenocorticotrophic Hormone-Dependent Adrenal Adenoma
por: Shakir, Mohamed K.M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lu4rhu567orq2r9en1fk8dpoj5